| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69097-570-53 | 69097-570 | HUMAN PRESCRIPTION DRUG | Deferasirox | Deferasirox | GRANULE | ORAL | 20220223 | N/A | ANDA | ANDA215026 | Cipla USA Inc. | DEFERASIROX | 360 mg/1 | 30 PACKET in 1 CARTON (69097-570-53) / 1 GRANULE in 1 PACKET |
| 69097-560-53 | 69097-560 | HUMAN PRESCRIPTION DRUG | Deferasirox | Deferasirox | GRANULE | ORAL | 20220223 | N/A | ANDA | ANDA215026 | Cipla USA Inc. | DEFERASIROX | 180 mg/1 | 30 PACKET in 1 CARTON (69097-560-53) / 1 GRANULE in 1 PACKET |
| 69097-550-53 | 69097-550 | HUMAN PRESCRIPTION DRUG | Deferasirox | Deferasirox | GRANULE | ORAL | 20220223 | N/A | ANDA | ANDA215026 | Cipla USA Inc. | DEFERASIROX | 90 mg/1 | 30 PACKET in 1 CARTON (69097-550-53) / 1 GRANULE in 1 PACKET |